0000930413-12-003455.txt : 20120606
0000930413-12-003455.hdr.sgml : 20120606
20120606194235
ACCESSION NUMBER: 0000930413-12-003455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120605
FILED AS OF DATE: 20120606
DATE AS OF CHANGE: 20120606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conover Charles
CENTRAL INDEX KEY: 0001538563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12957
FILM NUMBER: 12893061
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000727510
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222372868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
STREET 2: ATT: GENERAL COUNSEL
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
BUSINESS PHONE: 732-980-4500
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
STREET 2: ATT: GENERAL COUNSEL
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20021211
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20021210
FORMER COMPANY:
FORMER CONFORMED NAME: ENZON INC
DATE OF NAME CHANGE: 19920703
4
1
c69934_4.xml
OWNERSHIP DOCUMENT
X0305
4
2012-06-05
0
0000727510
ENZON PHARMACEUTICALS INC
ENZN
0001538563
Conover Charles
C/O ENZON PHARMACEUTICALS, INC.
20 KINGSBRIDGE ROAD
PISCATAWAY
NJ
08854
0
1
0
0
SVP, R&D Program Management
Common Stock
2012-06-05
4
S
0
25000
6.78
D
57213
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.70 to $6.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Andrew Rackear, Attorney-in-Fact
2012-06-06